Frederick w goldberg (15 Ergebnisse)

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. pp. 332.

Hardcover. Zustand: Brand New. 1st edition. 318 pages. 9.75x6.50x1.00 inches. In Stock.

Zustand: New. In English.

Gebunden. Zustand: New. This is the first book to examine the future opportunities and challenges in the development of drugs which target kinases&Uumlber den AutorrnrnDr Richard A Ward is a Computational Chemist, Oncology iMed, at AstraZeneca, UK. He received his.

Hardcover. Zustand: Brand New. 413 pages. 9.50x6.50x1.25 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 318 pages. 9.75x6.50x1.00 inches. In Stock.

Zustand: New. In English.

Gebunden. Zustand: New. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years.&Uumlber den AutorrnrnDr Frederick W Goldberg is a Medicinal Chemist at AstraZeneca, UK. He received his MSci at Cambridge University.

Buch. Zustand: Neu. Neuware - Kinase inhibition remains an area of significant interest across academia and in the pharmaceutical industry. There are now many marketed drugs which target kinases and a significant number of compounds are currently in various stages of clinical development. Although there have been a number of publications on kinase inhibition, this is the first to examine the future opportunities and challenges in targeting this important family of enzymes. The book is forward-looking and focuses on a number of key areas for kinase inhibition over the coming years.…

Buch. Zustand: Neu. Neuware - Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.…

Zustand: New.